Chugai Pharmaceutical Co., Ltd.
4519
주식 순위
#350
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
주가
$41.60
시가총액
$68.46B
변동 (1일)
0.94%
변동 (1년)
-12.56%
국가
JP
거래 Chugai Pharmaceutical Co., Ltd. (4519)
카테고리
Healthcare
Chugai Pharmaceutical Co., Ltd. (4519)의 배당 이력
Chugai Pharmaceutical Co., Ltd. (주식 심볼: 4519)은 총 54회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): $1.07K
배당 수익률 (TTM): 0.0322
모든 배당금의 합계 (주식 분할 반영): $1.07K
배당 수익률 (TTM): 0.0322
Chugai Pharmaceutical Co., Ltd. (4519)의 2000부터 2026까지 배당 지급 내역
연간 배당 지급
| 연도 | 배당금 (주식 분할 조정됨) | 변화 |
|---|---|---|
| 2026 (TTM) | $66.00 | -75.74% |
| 2025 | $272.00 | 177.55% |
| 2024 | $98.00 | 22.50% |
| 2023 | $80.00 | 2.56% |
| 2022 | $78.00 | 2.63% |
| 2021 | $76.00 | 52.00% |
| 2020 | $50.00 | 7.14% |
| 2019 | $46.67 | 62.79% |
| 2018 | $28.67 | 38.71% |
| 2017 | $20.67 | 19.23% |
| 2016 | $17.33 | -10.34% |
| 2015 | $19.33 | 20.83% |
| 2014 | $16.00 | 6.67% |
| 2013 | $15.00 | 12.50% |
| 2012 | $13.33 | 0.00% |
| 2011 | $13.33 | 0.00% |
| 2010 | $13.33 | 0.00% |
| 2009 | $13.33 | 17.65% |
| 2008 | $11.33 | 13.33% |
| 2007 | $10.00 | 0.00% |
| 2006 | $10.00 | 36.36% |
| 2005 | $7.33 | 22.22% |
| 2004 | $6.00 | -14.29% |
| 2003 | $7.00 | 31.25% |
| 2002 | $5.33 | -8.57% |
| 2001 | $5.83 | 27.27% |
| 2000 | $4.58 | 0.00% |
모든 배당 지급 목록
| 연도 | 배당금 | 변화 |
|---|---|---|
| 2026 (TTM) | $66.00 | -75.74% |
| 2025 | $272.00 | 177.55% |
| 2024 | $98.00 | 22.50% |
| 2023 | $80.00 | 5.26% |
| 2022 | $76.00 | 0.00% |
| 2021 | $76.00 | 52.00% |
| 2020 | $50.00 | -64.29% |
| 2019 | $140.00 | 62.79% |
| 2018 | $86.00 | 38.71% |
| 2017 | $62.00 | 19.23% |
| 2016 | $52.00 | -10.34% |
| 2015 | $58.00 | 20.83% |
| 2014 | $48.00 | 6.67% |
| 2013 | $45.00 | 12.50% |
| 2012 | $40.00 | 0.00% |
| 2011 | $40.00 | 0.00% |
| 2010 | $40.00 | 0.00% |
| 2009 | $40.00 | 17.65% |
| 2008 | $34.00 | 13.33% |
| 2007 | $30.00 | 0.00% |
| 2006 | $30.00 | 36.36% |
| 2005 | $22.00 | 22.22% |
| 2004 | $18.00 | -14.29% |
| 2003 | $21.00 | 31.25% |
| 2002 | $16.00 | -8.57% |
| 2001 | $17.50 | 27.27% |
| 2000 | $13.75 | 0.00% |
유사 기업 또는 경쟁사의 배당 지급
| 회사 | 배당 지급 횟수 | 국가 |
|---|---|---|
| 217.00% |
US
|
|
| 228.00% |
US
|
|
| 56.00% |
US
|
|
| 225.00% |
US
|
|
| 33.00% |
CH
|
